Tuesday, January 24, 2012
Thursday, January 19, 2012
Tuesday, January 10, 2012
-
Going Nuc-lear on Hepatitis C -- Is Idenix the Next Target? (ABT, ACHN, BMY, GILD, IDIX, INHX, JNJ, Long Ideas, MRK, News, NVS, PFE, VRTX, VRUS, Short Ideas, Price Target, Rumors, M&A, Events, Intraday Update, Analyst Ratings, Movers, Trading Ideas / Tue, 03:54pm)
Monday, January 09, 2012
Tuesday, December 27, 2011
Friday, December 16, 2011
-
Robert W. Baird Downgrades Pharmasset to Neutral (VRUS, Downgrades, Analyst Ratings / Fri, 11:51am)
-
Pharmasset Announces Intent to Amend QUANTUM Trial (News, VRUS, FDA / Fri, 09:00am)
Tuesday, December 06, 2011
-
Want More Tech ETFs? Global X Has Your Back (AAPL, AMZN, AVGO, HANS, INTC, MSFT, News, NUAN, ORCL, PRGO, QCOM, QQQ, Sector ETFs, VRUS, Broad U.S. Equity ETFs, Specialty ETFs, New ETFs, Intraday Update, Markets, Movers, Tech, Trading Ideas, ETFs / Tue, 03:58pm)
Monday, December 05, 2011
-
Citi Reiterates Buy, $49 PT on Gilead (Analyst Color, GILD, News, VRUS, Price Target, Reiteration, FDA, Intraday Update, Markets, Analyst Ratings, Movers, Trading Ideas / Mon, 01:11pm)
-
J.P. Morgan Reiterates Overweight On Gilead (Analyst Color, GILD, News, VRUS, Reiteration, FDA, Intraday Update, Markets, Analyst Ratings, Movers, Trading Ideas / Mon, 01:07pm)
Thursday, December 01, 2011
Tuesday, November 29, 2011
-
Brean Murray Raises Inhibitex PT to $19 From $12 (Analyst Color, GILD, INHX, Long Ideas, News, VRUS, Price Target, Reiteration, FDA, Intraday Update, Markets, Analyst Ratings, Trading Ideas / Tue, 01:25pm)
Monday, November 28, 2011
-
Deutsche Bank Has Buy, $53 PT On Gilead (Analyst Color, GILD, News, VRUS, Price Target, Reiteration, FDA, M&A, Intraday Update, Markets, Analyst Ratings, Trading Ideas / Mon, 12:37pm)
Friday, November 25, 2011
Tuesday, November 22, 2011
-
End-of-Day Market Summary for November 22, 2011 (BHO, BRCD, CISG, DLB, FMCN, FRO, MRK, News, NUAN, P, SFL, SIRI, STP, TIVO, TLR, VRUS, WIN, Broad U.S. Equity ETFs, Upgrades, Downgrades, Contracts, Legal, Events, Global, Econ #s, Economics, After-Hours Center, Markets, Analyst Ratings, Movers, Tech, Reviews, ETFs / Tue, 05:15pm)
-
Brean Murray Downgrades Pharmasset to "Hold" (Analyst Color, GILD, News, VRUS, Downgrades, Price Target, FDA, M&A, Intraday Update, Markets, Analyst Ratings, Movers, Trading Ideas / Tue, 12:29pm)
-
Brean Murray Downgrades Pharmasset to Hold, Removes PT (VRUS, Downgrades, Price Target, Analyst Ratings / Tue, 11:47am)
-
Leerink Downgrades Pharmasset to Market Perform (VRUS, Downgrades, Pre-Market Outlook, Analyst Ratings / Tue, 08:46am)
-
Canaccord Downgrades Pharmasset to Hold (GILD, VRUS, Downgrades, Pre-Market Outlook, Analyst Ratings / Tue, 08:20am)
-
UBS Downgrades Pharmasset to Neutral (GILD, VRUS, Downgrades, Price Target, Pre-Market Outlook, Analyst Ratings / Tue, 08:19am)
-
Benzinga's Top Downgrades (DOLE, SMP, TSL, VRUS, Downgrades, Analyst Ratings / Tue, 08:04am)
-
Idenix and Spectrum Pharmaceuticals to Open Near 52-Week Highs (BIIB, GILD, IDIX, Long Ideas, SPPI, VRUS, Short Ideas, Pre-Market Outlook, Trading Ideas / Tue, 07:49am)
Monday, November 21, 2011
-
Hep-C Stocks Soar On M&A News (ACHN, BMY, GILD, INHX, Long Ideas, News, VRTX, VRUS, Short Ideas, Rumors, FDA, M&A, Hot, Intraday Update, Markets, Trading Ideas / Mon, 02:14pm)
-
What's Next for Hep C Drug Stocks Following Gilead's $11B Pharmasset Buy? (GILD, ROI, VRUS, General / Mon, 02:14pm)
